bibliographic resource 275924 [br/275924]
https://w3id.org/oc/corpus/br/275924

is a

• document
• article

title

• Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

publication date

• 2013-01-01

contributor

• https://w3id.org/oc/corpus/ar/787626
• https://w3id.org/oc/corpus/ar/787627
• https://w3id.org/oc/corpus/ar/787628
• https://w3id.org/oc/corpus/ar/787629
• https://w3id.org/oc/corpus/ar/787630
• https://w3id.org/oc/corpus/ar/787631
• https://w3id.org/oc/corpus/ar/787632
• https://w3id.org/oc/corpus/ar/787633
• https://w3id.org/oc/corpus/ar/787634
• https://w3id.org/oc/corpus/ar/787635
• https://w3id.org/oc/corpus/ar/787636
• https://w3id.org/oc/corpus/ar/787637
• https://w3id.org/oc/corpus/ar/787638
• https://w3id.org/oc/corpus/ar/787639
• https://w3id.org/oc/corpus/ar/787640

format

• https://w3id.org/oc/corpus/re/104026

identifier

• https://w3id.org/oc/corpus/id/404639
• https://w3id.org/oc/corpus/id/404640
• https://w3id.org/oc/corpus/id/404641

part of

• https://w3id.org/oc/corpus/br/5160